Skip to content
Review Open access

Common metabolic, environmental, and molecular mechanisms underlying neurodevelopmental and neurodegenerative disorders

Sep 2026 · Frontiers in Neurology · Vol 17 · 0 citations · 143 references
Medicine

TL;DR

This review critically evaluates the experimental, epidemiological, and mechanistic evidence linking early-life metabolic and environmental insults with the establishment of latent vulnerability and proposes that this status may remain clinically silent for decades until activated by aging and cumulative stressors, ultimately leading to neurodegeneration.

Abstract

Several neurodevelopmental disorders and neurodegenerative diseases share common pathogenic mechanisms that unfold across the lifespan, blurring the distinction between the two nosological entities. Environmental factors, particularly those shaping metabolic health during critical developmental time windows, have emerged as key modulators of long-term brain liabilities. This review critically evaluates the experimental, epidemiological, and mechanistic evidence linking early-life metabolic and environmental insults with the establishment of latent vulnerability. We propose that this status may remain clinically silent for decades until activated by aging and cumulative stressors, ultimately leading to neurodegeneration. Specifically, we analyze how early metabolic alterations disrupt mitochondrial function, redox signaling, synaptogenesis, and glial programming, particularly in microglia, thereby shaping long-term neuroinflammatory tone and dysfunctional neural circuit maturation. The review highlights the role of the α7 nicotinic acetylcholine receptor (α7nAChR) as a strategic molecular bridge onto which metabolic and inflammatory signals converge. We further discuss how early dysregulatory stressors manifest later in life as dysmetabolism, vascular impairment, and defective energy sensing, all of which accelerate neurodegenerative pathophysiological processes. This life-course perspective reframes these disorders as a continuum and highlights critical prophylactic and/or therapeutic opportunities through early nutritional, metabolic, and environmental interventions.

Read PDF

Similar papers

Review Aug 2026

Neuro-Metabolic Ageing Drives Diabetes-Associated Neurodegeneration: A Geroscience and Network Pharmacology Perspective.

Ageing destabilizes metabolic and neuronal regulatory networks, increasing vulnerability to type 2 diabetes (T2D) and neurodegenerative disorders. These conditions are not independent disease entities but interconnected manifestations of accelerated neuro-metabolic ageing, driven by convergent impairments in insulin si...

Sakshi Tiwari, B. Siddiqui, Saman Fatima et al. · 0 citations
Review Sep 2026

Neuroepigenetics of the Environmental Exposome: Molecular and Clinical Implications in Neurodegeneration.

BACKGROUND Neuroepigenetics studies the molecular mechanisms that regulate gene expression in the nervous system without altering the DNA sequence. The environmental exposome has emerged as a key factor influencing neuronal plasticity and brain homeostasis, contributing to vulnerability to neurodegeneration. REVIEW S...

Elizabeth Avendaño-Arango, Isabella Salom-Palacio, E. Castillo-Támara et al. · 0 citations
Review Aug 2026

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Therapeutic Advances.

It is demonstrated that mitochondrial impairment precedes classical neuropathological hallmarks, thereby positioning mitochondrial dysfunction as a primary driver rather than a secondary consequence of neurodegeneration, and critically evaluates the translational landscape of mitochondria-targeted interventions.

Zhaomin Yao, Yang-Wa Wei, Weiming Xie et al. · 0 citations
Review Open access Sep 2026

Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration

Cellular senescence during brain aging is a complex biological phenomenon triggered by age-related and external factors, leading to epigenetic and genetic alterations that impair cellular replication, cause mitochondrial dysfunction, and activate the senescence-associated secretory phenotype (SASP). This activation ini...

Vega-García Angélica, Manuel-Apolinar Leticia, Feria-Romero Iris Angélica et al. · 0 citations
Review Aug 2026

Neuroinflammatory and molecular pathways in Alzheimer’s disease: mechanistic crosstalk and emerging therapeutic opportunities

Overall, this review makes a case for integrative, pathway-based therapeutic models, and multiple approaches may facilitate for drug development, biomarker identification and patient management in Alzheimer's disease.

Abhay Thakur, Rohit Sharma, Sneha Kumari et al. · 0 citations
Review Open access Aug 2026

Environmental determinants of neurotoxicity: role of heavy metals in neurological disorders

This review integrates multidisciplinary evidence to elucidate the mechanism and emphasizes environmental risk mitigation and translational strategies to reduce disease burden and promote lifelong brain resilience.

Snehashis Mandal, Priti Dipa, Neha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.